Knock down of the dual functional protein apurinic /apyrimidinic endonuclease 1 enhances the killing effect of hematoporphrphyrin derivative-mediated photodynamic therapy on non-small cell lung cancer cells in vitro and in a xenograft model

Cancer Science

Volumn 101, Issue 1, 2010, Pages 180-187

  Yang, Zhen Zhou ^a   Li, Meng Xia ^a   Zhang, Yun Song ^a   Xiang, De Bing ^a   Dai, Nan ^a   Zeng, Lin Li ^a   Li, Zeng Peng ^a   Wang, Ge ^a   Wang, Dong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE 1; ENHANCED GREEN FLUORESCENT PROTEIN; HEMATOPORPHYRIN DERIVATIVE; HYPOXIA INDUCIBLE FACTOR 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CELL KILLING; CONTROLLED STUDY; DNA REPAIR; DRUG EFFICACY; DRUG TARGETING; ENZYME INDUCTION; GENE ACTIVATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; NUDE MOUSE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN TARGETING; SINGLE STRANDED DNA BREAK; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DNA DAMAGE; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; GENE THERAPY; HEMATOPORPHYRINS; HUMANS; LUNG NEOPLASMS; MICE; PHOTOCHEMOTHERAPY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 71949087569     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01366.x     Document Type: Article

References (34)

1. Harrod-Kim P. Tumor ablation with photodynamic therapy: introduction to mechanism and clinical applications. J Vasc Interv Radiol 2006, 17:1441-8.
2. Solban N, Rizvi I, Hasan T. Targeted photodynamic therapy. Lasers Surg Med 2006, 38:522-31.
3. Plaetzer K, Krammer B, Berlanda J. Photophysics and photochemistry of photodynamic therapy: fundamental aspects. Lasers Med Sci 2009, 24:259-68.
4. Oleinick NL, Evans HH. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat Res 1998, 150:S146-56.
5. Buytaert E, Dewaele M, Agostinis P. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta 2007, 1776:86-107.
6. Mennel S, Meyer CH, Callizo J. Combined intravitreal anti-vascular endothelial growth factor (Avastin) and photodynamic therapy to treat retinal juxtapapillary capillary haemangioma. Acta Ophthalmol 2009, doi
7. Nowis D, Legat M, Grzela T. Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity. Oncogene 2006, 25:3365-74.
8. Maynard S, Schurman SH, Harboe C. Base excision repair of oxidative DNA damage and association with cancer and aging. Carcinogenesis 2009, 30:2-10.
9. Wang J, Yi J. Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol Ther 2008, 7:1875-84.
10. Fishel ML, Kelley MR. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target. Mol Aspects Med 2007, 28:375-95.
11. McNeill DR, Lam W, Deweese TL. Impairment of APE1 function enhances cellular sensitivity to clinically relevant alkylators and antimetabolites. Mol Cancer Res 2009, 7:897-906.
12. Farkasova T, Gurska S, Witkovsky V. Significance of amino acid substitution variants of DNA repair genes in radiosusceptibility of cervical cancer patients: a pilot study. Neoplasma 2008, 55(4):330-7.
13. McNeill DR, Wilson DM. A dominant-negative form of the major human abasic endonuclease enhances cellular sensitivity to laboratory and clinical DNA-damaging agents. Mol Cancer Res 2007, 5:61-70.
14. Bhakat KK, Mantha AK, Mitra S. Transcriptional regulatory functions of mammalian AP-endonuclease (APE1/Ref-1), an essential multifunctional protein. Antioxid Redox Signal 2009, 11:621-38.
15. Georgiadis MM, Luo M, Gaur RK. Evolution of the redox function in mammalian apurinic/apyrimidinic endonuclease. Mutat Res 2008, 643:54-63.
16. Luo M, Delaplane S, Jiang A. Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1. Antioxid Redox Signal 2008, 10:1853-67.
17. Xanthoudakis S, Smeyne RJ, Wallace JD. The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice. Proc Natl Acad Sci U S A 1996, 93:8919-23.
18. Breit JF, Ault-Ziel K, Al-Mehdi AB. Nuclear protein-induced bending and flexing of the hypoxic response element of the rat vascular endothelial growth factor promoter. FASEB J 2008, 22:19-29.
19. Ziel KA, Grishko V, Campbell CC. Oxidants in signal transduction: impact on DNA integrity and gene expression. FASEB J 2005, 19:387-94.
20. Jiang Y, Guo C, Vasko MR. Implications of apurinic/apyrimidinic endonuclease in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons. Cancer Res 2008, 68:6425-34.
21. Paap B, Wilson DM, Sutherland BM. Human abasic endonuclease action on multilesion abasic clusters: implications for radiation-induced biological damage. Nucleic Acids Res 2008, 36:2717-27.
22. Xiang DB, Chen ZT, Wang D. Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo. Cancer Gene Ther 2008, 15:625-35.
23. Li MX, Wang D, Zhong ZY. Targeting truncated APE1 in mitochondria enhances cell survival after oxidative stress. Free Radic Biol Med 2008, 45:592-601.
24. Abou-Khalil S, Abou-Khalil WH, Planas L. Interaction of rhodamine 123 with mitochondria isolated from drug-sensitive and -resistant Friend leukemia cells. Biochem Biophys Res Commun 1985, 127:1039-44.
25. Kim KS, Rajagopal V, Gonsalves C. A novel role of hypoxia-inducible factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells. J Immunol 2006, 177:7211-24.
26. Rashid G, Bernheim J, Green J. Parathyroid hormone stimulates the endothelial expression of vascular endothelial growth factor. Eur J Clin Invest 2008, 38:798-803.
27. Hilf R. Mitochondria are targets of photodynamic therapy. J Bioenerg Biomembr 2007, 39:85-9.
28. Haylett AK, Ward TH, Moore JV. DNA damage and repair in Gorlin syndrome and normal fibroblasts after aminolevulinic acid photodynamic therapy: a comet assay study. Photochem Photobiol 2003, 78:337-41.
29. Mitra S, Cassar SE, Niles DJ. Photodynamic therapy mediates the oxygen-independent activation of hypoxia-inducible factor 1alpha. Mol Cancer Ther 2006, 5:3268-74.
30. Luo M, Kelley MR. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone. Anticancer Res 2004, 24:2127-34.
31. Wang D, Xiang DB, Yang XQ. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells. 2009, doi:
32. Jarvi MT, Niedre MJ, Patterson MS. Singlet oxygen luminescence dosimetry (SOLD) for photodynamic therapy: current status, challenges and future prospects. Photochem Photobiol 2006, 82:1198-210.
33. Hofer T, Desbaillets I, Höpfl G. Dissecting hypoxia-dependent and hypoxia-independent steps in the HIF-1alpha activation cascade: implications for HIF-1alpha gene therapy. FASEB J 2001, 15:2715-7.
34. Vascotto C, Cesaratto L, Zeef LA. Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells. Proteomics 2009, 9:1058-74.